Endocytic entry of HIV-1

被引:116
|
作者
Fackler, OT
Peterlin, BM [1 ]
机构
[1] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
关键词
D O I
10.1016/S0960-9822(00)00654-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enveloped viruses enter target cells by membrane fusion or endocytosis. In the latter case, fusion of the viral envelope is induced by the acidic pH of the endocytic vesicle [1]. As with most other retroviruses, entry of the human immunodeficiency virus (HIV) is thought to be exclusively by pH-independent membrane fusion after interaction of its envelope with CD4 and a chemokine co-receptor on the target cell [2,3]. Expression of CD4 on the virus producing cell impairs the release and infectivity of HIV-1(NL4-3) particles [4-6]. In sharp contrast, we found that the infectivity of another HIV isolate, HIV-1(SF2), was enhanced by expression of CD4 on the producer cells, which correlated with significantly increased amounts of viral proteins in the vesicular fraction of target cells. Endocytic inhibitors decreased infectivity of HIV-1(SF2) but enhanced that of HIV-1(NL4-3). Expression of CD4 in the producer cell did not remove gp41 from HIV-1(SF2) virions. With these cells, the formation of syncytia could be induced by acidic medium. Thus, HIV-1(SF2) can enter the cytoplasm by an endocytic route after activation of gp41 by the acidic pH of endocytic vesicles. Endocytic entry might expand the range of cells that HIV could infect and should be considered in antiviral strategies against AIDS.
引用
收藏
页码:1005 / 1008
页数:4
相关论文
共 50 条
  • [1] STUDIES ON HIV-1 ENTRY
    ROBINSON, HL
    FERNANDEZLARSSON, R
    LU, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 : S84 - S84
  • [2] Inhibitors of HIV-1 Entry
    Micewicz, Ewa D.
    Ruchala, Piotr
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (10) : 1784 - 1799
  • [3] Reversible and Efficient Activation of HIV-1 Cell Entry by a Tyrosine-Sulfated Peptide Dissects Endocytic Entry and Inhibitor Mechanisms
    Platt, Emily J.
    Gomes, Michelle M.
    Kabat, David
    JOURNAL OF VIROLOGY, 2014, 88 (08) : 4304 - 4318
  • [4] HIV-1 entry and entry inhibitors as therapeutic agents
    Starr-Spires, LD
    Collman, RG
    CLINICS IN LABORATORY MEDICINE, 2002, 22 (03) : 681 - +
  • [5] The cell biology of HIV-1 entry
    Blumenthal, Robert
    Finnegan, Catherine M.
    Viard, Mathias
    Rawat, Satinder S.
    Puri, Anu
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [6] Stoichiometric parameters of HIV-1 entry
    Zan, Melissa
    Siliciano, Robert
    VIROLOGY, 2015, 474 : 1 - 9
  • [7] HIV-1 entry inhibitor entrances
    Kuhmann, SE
    Moore, JP
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (03) : 117 - 120
  • [8] HIV-1 entry and how to block it
    Brelot, A
    Alizon, M
    AIDS, 2001, 15 : S3 - S11
  • [9] OTHER DETERMINANTS OF HIV-1 ENTRY
    NARA, PL
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S135 - S135
  • [10] Natural barrier to HIV-1 entry
    Flight, Monica Hoyos
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) : 436 - 436